TCG Labs-Soleil
Harding L. is currently serving as the VP of Discovery Research and Co-Founder at TCG Labs-Soleil. Prior to this role, Harding held various positions at NGM Biopharmaceuticals, including Director of Biology, Scientist II, and Scientist I. Harding completed a Ph.D. in Immunobiology at Yale School of Medicine after obtaining a Bachelor's Degree in Molecular, Cell, and Developmental Biology from UCLA.
TCG Labs-Soleil
At TCG Labs-Soleil, we are establishing a pioneering venture-biotech model in collaboration with The Column Group. Our mission is to efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.